Back to LLY
MACKENZIE FINANCIAL CORP → LLY
MACKENZIE FINANCIAL CORP LLY Position History
Eli Lilly and Company • Healthcare
Quarters held
5
Latest value
$697.8M
Q3 2026
Peak value
$697.8M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $199.4M |
| Q4 2025 | $529.5M |
| Q1 2026 | $465.5M |
| Q2 2026 | $696.2M |
| Q3 2026 | $697.8M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $697.8M | 603.1K | — | — |
| Q2 2026 | $696.2M | 580.5K | — | — |
| Q1 2026 | $465.5M | 506.1K | — | — |
| Q4 2025 | $529.5M | 491.3K | — | — |
| Q3 2025 | $199.4M | 261.3K | — | — |
Other funds holding LLY
$108.4B
$104.2B
$99.1B
$84.5B
$79.5B
$72.9B
$62.3B
$59.7B